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Abstract: 
Background: Perforin″PRF1″ is a fenestrae-framing peptide whichhas the capacity of ″toxic 
lymphocytes″, which slaughter changed cells as well as cells harboring intracellular 
pathogens(Voskoboinik and Trapani 2006).These lymphocytes traverse both the intrinsic and 
versatile safe compartments, and include ″toxic T lymphocytes″, regular executioner killer 
cells, Natural killercells.Thesecytes can release ″PRF1″continuously sending warning 
signals.″PRF1″ is placed in the cellular parts that are released in a cellular way to empty their 
contents, performing their role as target cells (Voskoboiniket.al 2010). 
        The goal of this study is to discover a specific marker can detect or prevent superficial 
bladder cancer in men using malignant biopsies of bladder for this purpose. 
Methods: 
        Envision technique was used on tissue samples taken from 15 men with urothelial cancer 
and 15 other men with benign were adopted as  a control group. Cancer cells were inferred 
using perforinmarker. 
 
Results: 
        The results showed a significant increase (P<0.05) in the level of perforin expression in 
malignant cells in contrast to that in benign cells which demonstrated negative level of perforin 
expression. 
Conclusion: 
       It was concluded from the present study results the main role of perforin as a diagnostic 
marker in urothelial cancer disease, especially in the initial state of disease. 
Keywords: Perforin , tumor marker , Urothelial Cancer. 
Introduction 
         Perforin is a protein that forms cellular holes found in granules within lymphatic cells and 
When these granules decompose, perforin moves to the plasma membrane of the cell forming 
short chains and with calcium forming the cellular holes.The pore framed takes into 
consideration the aloof dispersion of a group of expert ″apoptotic proteases″, define as the 
″granzymes″, through  objective cell(Trapani 1996).Perforin has basic and utilitarian 
similitudes to supplement segment (C9) and the lytic film embeddings part of 
perforin(Tschoppet.al 1986). 
       This locale imparts homology to cholesterol-subordinate cytolysins from Gram-positive 
bacteria(Rosado et.al 2007).Such as″C9″, perforin makes transmembrane tubules and is 
equipped for degrade non-particularly an assortment of goal cells.Perforin is expected to work 
throughmaking openings in the cell membrane film which induce releasing a deluge of calcium 
and starts layer reconstitute systemswhich makes″perforin″ in a primary internal somes(Thiery 
et.al 2011). 
″Urinary bladder″ malignancies constitute fifth driving reason for growth passing among guys 
in Western nations. The larger part (>90%) are urothelial carcinomas ″UCs″ (Ebleet.al 
2004).Most of the mortalityhappens in persons who give intrusive ″UCs″, portrayed by a 
largeinvasion rate andwide broad comprehension for sub-atomic components hidden UC 
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attack, the primary occasion in metastasis, is expected to discover sub-atomic markers 
foreseeing malady movement and to create enhanced helpful focuses for treatment of obtrusive 
UCs (Black and Dinney 2007 ,Egeblad and Werb 2002 ,Obrien et.al 2008). 
″Granzyme Gr B″ is a serine proteinase contained, together with different Grs and ″perforin 
PRF″, in cellularvesicles of enacted ″cytotoxic T lymphocytes CTLs″ and common executioner 
″NK″ cells(Russell 2002 and Ley ,Bleackley 2005) .On effector-target cell association, GrB is 
exocytosed and conveyed by methods for Perforin in the liquid cytoplasm ″cytosol″of target 
cells, where it initiates the programmed cell death ″apoptosis″ through protein degradation of 
internal substrates(Chowdhury and Lieberman 2008 , Cullen and Martin 2008 , Besencaret.al 
2008 ) 
        The present study was designed to estimate the content of perforinin tissue samples with 
urothelial cancer in an attempt to detect the possible role of perforinand to benefit from future 
results and their applicability in the diagnosis, prevention or treatment of this disease.   
Materials and Methods:  
Subjects and samples 
     The present investigation included 15 patients of Iraqi males with urothelial carcinoma and 
other 15 males with benign as control gather . The blood were taken from the patients at 
alsader therapeutic city healing facility in najaf,also biopsies have been taken for each 
patient.The patients were partitioned into four stages and three grades, the stages are 
Ta,T1,T2,T3,and the grades are I,II,III (WHO,2010) ,additionally into four subdivisions as 
indicated by ages (40-49Y),(50-59Y),(60-69Y),(70-80Y),and two subdivisions smokers and 
non smokers.The control bunch comprise of 15 benign tissue samples (biopsies) brought from 
patients with urothelial cancer. 
Perforin assessment: 
        Envision system strategy have been utilized as a part of different strides for perforin 
location through immunohistochemicalstaining procedure by using blue hematoxylene stain 
,from essential counter acting agent to catalyst, to be refined in asingle step. 
Results: 
        The outcomes demonstrated the critical expanding of perforinexpression in the urothelial 
malignant samples in examination with those of benign. The percent of expression expanded 
with the movement of the stage and the grade of tumor.The comes about likewise showed a 
noteworthy height of perforinexpression in all periods of patients particularly assemble of(70-
79Y).Result of smokers patients have clarified huge expression (p< 0.05) in examination with 
non-smokers patients (Table 1, Fig.2,3). 
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Table (1 ) indicate higher percentages of perforin expression in advanced stages of disease 
(T3),(G3) ,also in older patients (70-80 Y),and in smoking conditions. 
All cases Number 15 Neg/weak % Moderate % Strong  % P value 
Stages      
P Ta 8 10 44 46  
P T1 4 13 28 59  
P T2 2 9 25 66  
P T3 1 0 24 76 p< 0.05 
Grades      
P G1 11 8 40 52  
P G2 3 18 41 41  
P G3 1 2 29 69 p< 0.05 
Ages      
P (40-49 Y) 1 18 30 52  
P (50-59 Y) 2 12 30 58 p<0.05 
P (60-69 Y) 10 18 19 63  
P (70-80 Y) 2 3 17 80  
Smoking      
P Smokers 10 5 33 62 p<0.05 
P non-
Smokers 
5 76 11 13  
         
     The paradigm for positive immunohistochemistry(IHC)was dull darker hasten at all 
cytoplasm ,The immunostaining demonstrated to immunoreactive cells per add up to size of 
malignantcells.Each test was checked with graduate power magnification.The 
immunohistochemicalstaining was assessed by Truls et al (2005). 
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Figure (1) (20x)cross histological section of normal human urinary bladder stained with 
perforin used as control, showing normal perforincontent.U:urothelium , L :laminaproperia , M 
:middle cells , B :basal cells. 
 
(a)                                                                 (b) 
Figure (2 ) cross histological section of malignant urinary bladder cells :(a 40x ,b 10x)brown 
color refers to moderate epithelial perforin expression in patient GI,Ta . 
Discussion: 
        Epithelial-mesemchymal progress ″EMT″ has risen like a first step in the 
intrusion of a several carcinomas(Thiery 2006)such as″UCs″(Lipponen and Eskelinen 
1995 , Lascombeet.al2006 , Baumgartet.al2007 , Bryan et.al2008). 
        A fundamental component of malignant tissues experiencing ″EMT″ is the 
absence of inter epithelial cellsconnections, bringing about a ″mesenchymal-like 
phenotype″malignantcells are separated from adjacent cells and increment their 
versatility gridding corruption abilities, in this way moving and invading . 
      It has been accounted for that downregulation or absence of film ″E-cadherin″ (in 
charge of the loss of cell bond), might be joined by carcino-articulation of ″N-
cadherin″, a protein found in themesenchyme(Lascombeet.al2006, Bryan et.al2008 ). 
       Study of Donatella 2010 demonstrated that″Granzyme B″is a protein has the 
ability of  serine degradationreleased by ″cytotoxic 
lymphocytes″stimulating,apoptosis in the presence of perforin in effector cellsand 
that urothelial malignancy growth lysates corrupted ″ECM″ segments, and this 
outcome is conversely with past information by Buzzaet.al 2005, who, steady with 
GrB-interceded dividing of integrin-subordinate cell grip, have appeared in vitro 
restraint of growing malignant cells, movement and attack by ″GrB″. 
The present examination uncovered profoundly expression rates of perforin in all 
stages and grades of urinary bladder malignancy cells (Table 1 ).study of Chia et.al 
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2009 demonstrated that PRF1 is probably going to ensure people against 
hematological malignancies, starting at all ″non-consanguineous″ patients who are 
explained″bi-allelic PRF1″ changes involving PRF1A91V. 
Joseph et.al 2013 found a negligible increment during recurrence of ″PRF1″ changes 
uponhigh number of melanoma patients (including″PRF1A91V-positive″ people,few 
other  patients bearing the uncommon ″PRF1R28C allele″ and one patient conveying 
PRF1N252S), as contrasted and a solid, sex coordinated control populace. 
perforin expression has been recognized in the epithelial and stromal cells of the 
urinary bladder lesions, and the epithelial cells might be the real wellspring of 
perforin articulation (Figure 2,3) and may be able to expand the movement of 
cancer.This result may concur with investigation of Lin et. al. ,(2011) which showed 
the overexpression of aromatase prompts expanded expansion in the urothelial layer. 
Conclusion: 
The present work showing that perforin after emission from tumor cells could go 
about as autocrine factors advancing neoplastic growth,and the perforinnonattendance 
in benign urinary bladder cells(Figure 1) may bolster this conclusion and may prompt 
utilize perforin as productive biomarker in the therapeutic administration to treat or 
counteract movement of urinary bladder malignancy and attack in men. 
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